65
Views
86
CrossRef citations to date
0
Altmetric
Original Article

Inner ear concentrations and ototoxicity of different antibiotics in local and systemic application

, , , &
Pages 350-363 | Published online: 07 Jul 2009
 

Abstract

The cause of the specific ototoxicity of antibiotics of the aminoglycosid group, like streptomycin, kanamycin, neomycin, gentamicin, may, as we could observe, be looked for in the specific accumulation of these substances both in the endolymph and perilymph of the internal ear. The toxicity may be explained by the high concentration of these antibiotics in the lymphatic fluid and by the fact, that they are retained there for a long time.

In a comparative study with isomolar doses of the toxic aminoglycosid antibiotics, both the extent of sensory (hair) cell damages using the surface preparation technique were evaluated and the antibiotic level was measured. It could be shown that the more toxic the substance, the higher was the concentration in the internal ear. This specific accumulation and toxicity, typical for each substance, could be found both in systemic intramuscular and direct (topical) application to the cochlea.

On the other hand, when other antibiotics were applied, either in a systemic or topical mode, basic differences became apparent. Thus, the neurotoxic polymyxins and tetracyclines, when applied intramuscularly, did not cause any damages to hearing because of their inability to penetrate the internal ear, that is, through the blood-lymph barrier. Topically applied, polymyxin causes severe sensory cell damages and, to a smaller extent, tetracycline, too. Furthermore, chloramphenicol topically applied, will cause sensory cell damages. The pronounced damages caused by the topical application of erythromycin, were also surprising. Only penicillin, independent of its mode of application, showed no internal ear damages, the result being identical with the control tests.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.